Iovance Biotherapeutics, Inc. (IOVA)

NASDAQ: IOVA · Real-Time Price · USD

3.480

-0.050 (-1.42%)

At close: Apr 23, 2026, 4:00 PM EDT

3.480

0.00 (0.00%)

Pre-market: Apr 24, 2026, 9:08 AM EDT

Iovance Biotherapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	263.5	164.07	1.19	-	-
Revenue Growth (YoY)	60.60%	13698.99%	-	-	-
Cost of Revenue	173.18	93.25	1.03	-	-
Gross Profit	90.32	70.82	0.16	-	-
Selling, General & Admin	152.32	152.27	106.1	104.1	83.66
Depreciation & Amortization Expenses	35.94	37.6	21.42	-	-
Research & Development	300.27	276.23	333.19	294.78	259.04
Other Operating Expenses	5.14	-	-	-	-
Total Operating Expenses	493.67	466.1	460.72	398.88	342.7
Operating Income	-403.36	-395.28	-460.56	-398.88	-342.7
Interest Income	10.31	20.27	13.04	2.99	0.45
Total Non-Operating Income (Expense)	10.31	20.27	13.04	2.99	0.45
Pretax Income	-393.05	-375.01	-447.52	-395.89	-342.25
Provision for Income Taxes	-2.07	-2.83	-3.48	-	-
Net Income	-390.98	-372.18	-444.04	-395.89	-342.25
Net Income to Common	-390.98	-372.18	-444.04	-395.89	-342.25
Shares Outstanding (Basic)	357	290	235	159	153
Shares Outstanding (Diluted)	357	290	235	159	153
Shares Change (YoY)	23.28%	23.28%	47.64%	3.82%	10.92%
EPS (Basic)	-1.09	-1.28	-1.89	-2.49	-2.23
EPS (Diluted)	-1.09	-1.28	-1.89	-2.49	-2.23
Shares Outstanding	411.94	305.25	256.14	187.81	157.01
Free Cash Flow	-336.24	-364.05	-384.11	-313.18	-265.52
Free Cash Flow Per Share	-0.94	-1.26	-1.63	-1.97	-1.73
Gross Margin	34.28%	43.17%	13.12%	-	-
Operating Margin	-153.08%	-240.92%	-38735.00%	-	-
Profit Margin	-148.38%	-226.84%	-37345.40%	-	-
FCF Margin	-127.61%	-221.89%	-32305.30%	-	-
EBITDA	-356.03	-347.21	-427.43	-377.74	-328.72
EBITDA Margin	-135.12%	-211.62%	-35948.90%	-	-
EBIT	-403.36	-395.28	-460.56	-398.88	-342.7
EBIT Margin	-153.08%	-240.92%	-38735.00%	-	-
Effective Tax Rate	0.53%	0.75%	0.78%	0.00%	0.00%

Updated Feb 24, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q